<DOC>
	<DOC>NCT00320203</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.</brief_summary>
	<brief_title>Anecortave Acetate in Patients With Open-angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients 18 years of age or older with openangle glaucoma. Other protocoldefined inclusion criteria may apply. Patients with openangle glaucoma with a pseudoexfoliation or pigment dispersion component. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>open-angle</keyword>
	<keyword>glaucoma</keyword>
</DOC>